Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular Degeneration

Affiliations

• ¹ New England Eye Center-Tufts Medical Center, Boston, Massachusetts; Department of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil.
• ² Department of Ophthalmology, Aneurin Bevan University Health Board, Newport, South Wales, United Kingdom.
• ³ Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
• ⁴ Sussex Eye Hospital, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom.
• ⁵ Department of Ophthalmology, Stoke Mandeville Hospital, Buckinghamshire, United Kingdom.
• ⁶ New England Eye Center-Tufts Medical Center, Boston, Massachusetts.
• ⁷ Center for Public Health, Queen's University of Belfast, Belfast, United Kingdom.
• ⁸ NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom.
• ⁹ Singapore National Eye Center, Singapore, Republic of Singapore.
• ¹⁰ Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
• ¹¹ New England Eye Center-Tufts Medical Center, Boston, Massachusetts; Ophthalmology Personalized Healthcare Program, Genentech Inc., South San Francisco, California.
• ¹² Vitreous Retina Macula Consultants of New York, New York, New York; New York University Grossman School of Medicine, New York, New York.
• ¹³ Department of Electrical Engineering and Computer Science, and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts.
• ¹⁴ Department of Ophthalmology, Inselspital, University Hospital Bern, Bern, Switzerland.
• ¹⁵ Division of Head and Neck, Ophthalmology Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
• ¹⁶ Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
• ¹⁷ Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
• ¹⁸ Doheny Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
• ¹⁹ Pharma Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
• ²⁰ Stein Eye Institute, University of California, Los Angeles, Los Angeles, California.
• ²¹ Vitreous Retina Macula Consultants of New York, New York, New York.
• ²² Department of Ophthalmology, University Eye Hospital, Vienna, Austria.
• ²³ Service d'Ophtalmologie, Hospital Intercommunal de Creteil, University Paris Est Creteil, Creteil, France.
• ²⁴ Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco," Sacco Hospital, University of Milan, Milan, Italy.
• ²⁵ Service d'Ophtalmologie, Hôpital Lariboisière, Université de Paris, Paris, France.
• ²⁶ Departments of Bioengineering and Ophthalmology, University of Washington, Seattle, Washington.
• ²⁷ Professor of Ophthalmology and Vision Science, Queen's University of Belfast, Belfast, United Kingdom; Consultant in Ophthalmology, The Belfast Trust, Belfast, United Kingdom.
• ²⁸ New England Eye Center-Tufts Medical Center, Boston, Massachusetts. Electronic address: nwaheed@tuftsmedicalcenter.org.